Wird geladen...

Single-agent and combination biologics in acute myeloid leukemia

Acute myeloid leukemia (AML) is a heterogeneous malignancy characterized by recurrent genetic, epigenetic, and metabolic abnormalities. As a result of our increasing knowledge of the underlying biology of AML leading to rational drug development, several new targeted agents have been recently added...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hematology Am Soc Hematol Educ Program
Hauptverfasser: Richard-Carpentier, Guillaume, DiNardo, Courtney D.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2019
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913489/
https://ncbi.nlm.nih.gov/pubmed/31808888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000059
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!